Ondansetron Oral Solution Clinical Trials

• Oral Disintegrating Ondansetron Tablet to Reduce Vomiting from Gastroenteritis in a Pediatric Emergency Department
  ClinicalTrials.gov Identifier: NCT00120744 - Active, not recruiting
  Gastroenteritis; Vomiting; Diarrhea; Dehydration
  
• Ondansetron for the Treatment of Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00040053 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Drug Treatment for Alcoholism (ondansetron)
  ClinicalTrials.gov Identifier: NCT00006205 - Recruiting
  Alcoholism
  
• Efficacy and Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00314743 - Recruiting
  Nausea; Vomiting
  
• The Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00149734 - Recruiting
  Schizophrenia
  
• Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00285272 - Recruiting
  Chemotherapy Induced Nausea and Vomiting; Non-Hodgkins Lymphoma; Multiple Myeloma
  
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00006348 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Ondansetron for the Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00033085 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule
  
• Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
  ClinicalTrials.gov Identifier: NCT00204165 - Active, not recruiting
  Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)
  ClinicalTrials.gov Identifier: NCT00199329 - Completed
  Postoperative Nausea and Vomiting
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
  ClinicalTrials.gov Identifier: NCT00319605 - Recruiting
  Epilepsy
  
• Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
  ClinicalTrials.gov Identifier: NCT00086281 - Active, not recruiting
  Obstructive Sleep Apnea Syndrome
  
• Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
  ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
  
• Aprepitant, Ondansetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00248547 - Active, not recruiting
  Cancer
  
• Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00529152 - Recruiting
  Iron Overload
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
  ClinicalTrials.gov Identifier: NCT00005668 - Completed
  Aspergillosis; Lung Diseases, Fungal
  
• An Open-Label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain
  ClinicalTrials.gov Identifier: NCT00465647 - Recruiting
  Acute Pain
  
• PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
  ClinicalTrials.gov Identifier: NCT00390598 - Active, not recruiting
  Colonoscopy
  
• Randomised Trial of Eutectic Mixture of Local Anaesthetics Cream and Oral Sucrose Solution for Venepuncture
  ClinicalTrials.gov Identifier: NCT00470080 - Not yet recruiting
  Pain
  
• A Comparison of GV Mouth Washes,Nystatin,Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
  ClinicalTrials.gov Identifier: NCT00128323 - Active, not recruiting
  Oropharyngeal candidiasis
  
• Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
  Hepatitis C
  
• A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
  ClinicalTrials.gov Identifier: NCT00437229 - Active, not recruiting
  Healthy Adult Volunteer
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Combined Pharmacotherapies for Alcoholism (naltrexone/ondansetron)
  ClinicalTrials.gov Identifier: NCT00027079 - Completed
  Alcoholism
  
• Ondansetron Treatment for Alcoholism
  ClinicalTrials.gov Identifier: NCT00000443 - Completed
  Alcoholism
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00005994 - Active, not recruiting
  nausea and vomiting
  
• Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
  Cystic Fibrosis
  
• Wild Type p53 Adenovirus for Oral Premalignancies
  ClinicalTrials.gov Identifier: NCT00410865 - Active, not recruiting
  Mouth Cancer; Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity; Dysplasia/Carcinoma in Situ (CIS) of the Oral Pharynx
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
  ClinicalTrials.gov Identifier: NCT00132873 - Recruiting
  Narcolepsy
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
  ClinicalTrials.gov Identifier: NCT00154973 - Recruiting
  Oral Cancer
  
• Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
  ClinicalTrials.gov Identifier: NCT00250289 - Recruiting
  Halitosis; Oral Malodor; Bad Breath
  
• A study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial
  ClinicalTrials.gov Identifier: NCT00081653 - Active, not recruiting
  Osteoporosis
  
• A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00323518 - Active, not recruiting
  Oral Mucositis; Stomatitis
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
  ClinicalTrials.gov Identifier: NCT00002133 - Completed
  Candidiasis, Oral; HIV Infections
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• Pediatric Expanded Access Program-Oral Solution
  ClinicalTrials.gov Identifier: NCT00543530 - Completed
  HIV Infections
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• A Peri-Intubation Oral Intervention to Reduce Oral Flora and VAP
  ClinicalTrials.gov Identifier: NCT00248300 - Recruiting
  Pneumonia
  
• Effects of Oral Care in the Neuroscience ICU
  ClinicalTrials.gov Identifier: NCT00518752 - Recruiting
  Ventilator Associated Pneumonia; Oral Hygiene
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Oral Budesonide vs. Oral Mesalazine in Active CD
  ClinicalTrials.gov Identifier: NCT00300118 - Recruiting
  Crohn's Disease
  
• Efficacy and Safety Study for an Oral Contraceptive Containing Folate
  ClinicalTrials.gov Identifier: NCT00468481 - Recruiting
  Oral Contraception
  
• Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
  ClinicalTrials.gov Identifier: NCT00000111 - Active, not recruiting
  Mouth Diseases
  
• A Randomized Study of Sulindac in Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00299195 - Recruiting
  Leukoplakia, Oral; Benign Neoplasms
  
• Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00507182 - Recruiting
  Oral Cancer
  
• Dexamethasone 0.01% Solution for the Treatment of Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00111072 - Completed
  
  
• Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00502580 - Recruiting
  Oral Cancer
  
• In Vivo Confocal Imaging of Oral Mucosa
  ClinicalTrials.gov Identifier: NCT00502125 - Recruiting
  Oral Tumors
  
• Efficacy of Elidel Cream on Erosive Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00130572 - Recruiting
  Lichen Planus, Oral
  
• Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00355290 - Recruiting
  Blood Coagulation Disorders
  
• Fenretinide in Treating Patients With Leukoplakia of the Mouth
  ClinicalTrials.gov Identifier: NCT00004161 - Active, not recruiting
  prevention of oral cancer
  
• Elective vs Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00193765 - Recruiting
  Oral Cancer
  
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00323219 - Recruiting
  Cellulitis
  
• Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
  ClinicalTrials.gov Identifier: NCT00484822 - Recruiting
  Long-Term Oral Anticoagulant Therapy
  
• Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
  ClinicalTrials.gov Identifier: NCT00003817 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; Quality of Life; nausea and vomiting
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00173849 - Not yet recruiting
  Oral Cancer
  
• Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
  ClinicalTrials.gov Identifier: NCT00119197 - Active, not recruiting
  Cholera
  
• Impact of Oral Ibandronate 150mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
  ClinicalTrials.gov Identifier: NCT00271713 - Active, not recruiting
  Osteoporosis, Postmenopausal
  
• Biomarkers for Oral Cancer
  ClinicalTrials.gov Identifier: NCT00341497 - Active, not recruiting
  Oral Cancer
  
• Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution
  ClinicalTrials.gov Identifier: NCT00367536 - Completed
  Postmenopause
  
• Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00499668 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol Specific
  
• Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
  ClinicalTrials.gov Identifier: NCT00232960 - Recruiting
  Oral Cancer; Oropharynx Cancer
  
• Enhancing Oral Health Care Use by HIV Positive Individuals
  ClinicalTrials.gov Identifier: NCT00444977 - Recruiting
  Oral Hygiene; HIV Infections; Mouth Diseases
  
• Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido
  ClinicalTrials.gov Identifier: NCT00566384 - Recruiting
  Decreased Libido
  
• UVB Phototherapy Treatment of Oral Chronic GVHD
  ClinicalTrials.gov Identifier: NCT00374257 - Recruiting
  Oral Chronic Graft-Versus-Host Disease
  
• Treatment of Oral Premalignant Lesions With 5-ALA PDT
  ClinicalTrials.gov Identifier: NCT00571974 - Recruiting
  Precancerous Lesions of the Oral Cavity; Leukoplakia; Erythroplakia
  
• RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
  ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
  lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
  
• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
  ClinicalTrials.gov Identifier: NCT00442312 - Active, not recruiting
  Glaucoma
  
• A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00176566 - Recruiting
  Oral Leukoplakia
  
• The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
  ClinicalTrials.gov Identifier: NCT00333749 - Recruiting
  Oral Ulcer
  
• An Exploratory Study on Optical Assessment of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00488332 - Recruiting
  Head and Neck Cancer; Oral Mucositis
  
• Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00173316 - Recruiting
  Oral Cancer
  
• Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00151060 - Active, not recruiting
  Prostate Cancer
  
• Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022594 - Active, not recruiting
  Neck Cancer; Oral Cancer; Throat Cancer
  
• Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography
  ClinicalTrials.gov Identifier: NCT00172965 - Recruiting
  Oral Cancers
  
• Efficacy of SNX-1012 in the Treatment of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00385515 - Recruiting
  Stomatitis; Oral Mucositis
  
• Oral Margin Spectroscopy Detection Using Optical Spectroscopy
  ClinicalTrials.gov Identifier: NCT00439205 - Recruiting
  Oral Tumors
  
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
  Cancer; oral complications of cancer and cancer therapy
  
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
  ClinicalTrials.gov Identifier: NCT00155337 - Recruiting
  Oral Leukoplakia
  
• Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006471 - Active, not recruiting
  Oral Cancer; Neck Cancer; Throat Cancer
  
• Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
  ClinicalTrials.gov Identifier: NCT00003686 - Active, not recruiting
  oral complications of cancer and cancer therapy; Quality of Life
  
• Toxicity Substudy of ESPRIT: TOXIL-2 Substudy
  ClinicalTrials.gov Identifier: NCT00147355 - Recruiting
  rIL-2-toxicity; interleukin-2 therapy; HIV